Environmental Impact Assessment Report for the 980-Ton Per Year Norfloxacin Production Technology Upgrade Project (Front-end Supplement) of Wanbangde Pharmaceutical Group Co., Ltd.

Date:

02 Mar,2021

Environmental Impact Assessment Report for the 980-Ton Per Year Norfloxacin Technology Upgrade Project (Phase II) of Wanbangde Pharmaceutical Group Co., Ltd.

Public Participation Statement for the Environmental Impact Assessment of Wanbangde Pharmaceutical Group Co., Ltd.'s 980-Ton Annual Production Capacity Technical Renovation Project for Norfloxacin (Phase II Supplement)

The full text is attached. Click to download (1)

Click to download (2)

He Song, inspector of the Department of West Asia and Africa at the Ministry of Commerce, and his delegation visited Wandeb Group for a research visit.

Lü Zhiliang, Minister of Organization and Standing Committee Member of the Taizhou Municipal Party Committee, visited Wanbangde Pharmaceutical Group to coordinate and address challenges hindering the company's development.

Related Recommendations

2025/04/15

Good News | Warm Congratulations to Wanbande Pharmaceutical Group Co., Ltd. (Registered Trademark: wepon), which has been honored with the third batch of the "Taizhou Time-Honored Brand" title!

2025/04/14

New peptide candidate compound: Preclinical studies in the metabolic field show promising progress.

2025/04/14

[“Station” Success Report] | Wanbangde Pharmaceutical Group’s Postdoctoral Research Workstation Gains New Talent, Accelerating the Advancement of Innovative Drug Development!

< 1 2 3 4...78 > proceed page

Website Development: China Enterprise Dynamics Taizhou

Business license